Related Experiment Video
Updated: Sep 19, 2025

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
The factor V H1327R (rs1800595) polymorphism is associated with venous thromboembolic events: a case-control study in
Ahmadreza Fahandej Sadi1, Jamileh Saberzadeh2,3, Ardeshir Bahmanimehr4
1Division of Hematology and Blood Bank, Department of Medical Laboratory Sciences, School of Paramedical Sciences.
Abstract:
Venous thromboembolism (VTE) is a complex condition influenced by genetic and acquired factors. While genetic variations in proteins like S, C, and antithrombin are known to play a role in VTE, some cases remain unexplained. This study aims to investigate other genetic variations, including Protein Z (rs3024731), FV (rs1800595), and FGA (rs6050), to understand their potential association with VTE risk. The study included 118 VTE patients and 118 healthy individuals with no history of thromboembolic disorders. Blood samples were collected from the patients for DNA extraction, and genotyping was carried out using the amplification refractory mutation system-PCR (ARMS-PCR) technique. The results were validated through DNA sequencing. Data analysis was done using SPSS 27 software. Analysis has revealed significant differences in the genotypic and allelic frequencies of the rs1800595 polymorphism between the control and case groups. It was found that individuals with the AG genotype had a 2.22 times higher likelihood of experiencing thrombophilia events [odds ratio (OR) = 2.229, P = 0.039, confidence interval (CI) = 95%], while the G allele increased the risk by 2.103 times (OR = 2.103, P = 0.047, CI = 95%). No significant correlation was observed between VTE and the rs3024731 and rs6050 polymorphisms. The rs1800595 polymorphism in the FV gene may be associated with an increased risk of thrombophilia in VTE patients.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

